| Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil. | |
| | |
MedLine Citation:
|
PMID: 19333805 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Brazil's large-scale, successful HIV/AIDS treatment programme is considered by many to be a model for other developing countries aiming to improve access to AIDS treatment. Far less is known about Brazil's important role in changing global norms related to international pharmaceutical policy, particularly international human rights, health and trade policies governing access to essential medicines. Prompted by Brazil's interest in preserving its national AIDS treatment policies during World Trade Organisation trade disputes with the USA, these efforts to change global essential medicines norms have had important implications for other countries, particularly those scaling up AIDS treatment. This paper analyses Brazil's contributions to global essential medicines policy and explains the relevance of Brazil's contributions to global health policy today. |
| | |
Authors:
|
A Nunn; E Da Fonseca; S Gruskin |
Related Documents
:
|
272235 - Objectives and criteria for the management of cleft lip and palate and the delivery of ... 8498705 - The limitations of orthodontic treatment. 9455745 - Nonprogressive cmv retinitis in aids patients with protease inhibitors therapy for aids. 2646855 - Digitalis toxicity. 18303115 - Impact of an extreme climatic event on community assembly. 1660385 - Treatment of impaired consciousness with lumbar punctures in a patient with cryptococca... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Global public health Volume: 4 ISSN: 1744-1706 ISO Abbreviation: Glob Public Health Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-03-31 Completed Date: 2009-07-01 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 101256323 Medline TA: Glob Public Health Country: England |
Other Details:
|
Languages: eng Pagination: 131-49 Citation Subset: IM |
Affiliation:
|
Division of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, RI, USA. amy_nunn@brown.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acquired Immunodeficiency Syndrome
/
drug therapy*,
economics Anti-HIV Agents / economics, therapeutic use* Brazil Commerce Drug and Narcotic Control / economics Drugs, Essential / economics, supply & distribution* Drugs, Generic / economics, supply & distribution* HIV-1 Health Policy / economics* Health Services Accessibility / economics* Human Rights / economics Humans International Cooperation World Health |
| Grant Support | |
ID/Acronym/Agency:
|
P30 AI042853-129005/AI/NIAID NIH HHS; P30 DA013868-01A19002/DA/NIDA NIH HHS; T32 DA013911-09/DA/NIDA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 0/Drugs, Essential; 0/Drugs, Generic |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enhancing HIV prevention requires addressing the complex relationship between prevention and treatme...
Next Document: Civil society and the negotiation of the Framework Convention on Tobacco Control.